Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphism of heparan sulfate proteoglycan (perlecan, HSPG2), lipid profiles and coronary artery disease in the Australian population.

Atherosclerosis - 1 Jan 2000

Cai H, Wang X L, Wilcken D E

Abstract excerpt

Perlecan is one of the three major classes of heparan sulfate proteoglycans (HSPGs) within the cardiovascular system; it interacts with lipid metabolism by binding to lipoprotein lipase (LpL) and apolipoprotein B (apo B) and may be related to vascular disease. We explored interactions between an HSPG2 polymorphism (BamHI marker), and apo B and coronary artery disease (CAD) in patients undergoing coronary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Coronary Disease
Share to Heparan Sulfate Proteoglycans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heparitin Sulfate

Share to Lipids

Share to Polymorphism, Genetic

Share to Protein Isoforms

Share to Proteoglycans

Source

Identifiers

PMID: 10580178
DOI: 10.1016/s0021-9150(99)00213-0

Genes

HSPG2
CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Genetic polymorphism of heparan sulfate proteoglycan (perlecan, HSPG2), lipid profiles and coronary artery disease in the Australian population.PMID 10580178Read ↗

Glucuronic Acid Epimerase (GLCE) Variant rs3865014 (A>G) Is Associated with BMI, Blood Hemoglobin, Hypertension, and Cerebrovascular Events, the TAMRISK Study.Semantic proximity Read ↗

Fibrinogen Polymorphisms and Atherothrombotic DiseaseSemantic proximity Read ↗

Interindividual transcriptional regulation of the human biglycan gene involves three common molecular haplotypes.Semantic proximity Read ↗

Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation.Semantic proximity Read ↗

Plasma haptoglobin concentrations are elevated in patients with coronary artery disease.Semantic proximity Read ↗

Fibrinogen genotype and risk of peripheral atherosclerosis.Semantic proximity Read ↗

Association of lipoprotein lipase gene polymorphisms with coronary artery disease.Semantic proximity Read ↗

DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population.Semantic proximity Read ↗

High density lipoproteins, genetic polymorphism for apo A-I and coronary artery disease.Semantic proximity Read ↗

Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.